14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $15.00 $15.00 Tuesday, 18th Apr 2023 AVEO stock ended at $15.00. During the day the stock fluctuated 0% from a day low at $15.00 to a day high of $15.00.
90 days $14.99 $15.00
52 weeks $3.41 $15.00

Historical AVEO Pharmaceuticals prices

Date Open High Low Close Volume
Apr 18, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 17, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 14, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 13, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 12, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 11, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 10, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 06, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 05, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 04, 2023 $15.00 $15.00 $15.00 $15.00 0
Apr 03, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 31, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 30, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 29, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 28, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 27, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 24, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 23, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 22, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 21, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 20, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 17, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 16, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 15, 2023 $15.00 $15.00 $15.00 $15.00 0
Mar 14, 2023 $15.00 $15.00 $15.00 $15.00 0
Click to get the best stock tips daily for free!

About AVEO Pharmaceuticals

AVEO Pharmaceuticals AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II ... AVEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT